JUN 11, 2021 8:16 AM PDT

Laughing Gas Shows Promise in Rapid Relief of Treatment-Resistant Depression

WRITTEN BY: Annie Lennon

Researchers led by the University of Chicago Medicine and Washington University have found that low doses of laughing gas, also known as nitrous oxide, can relieve symptoms of treatment-resistant depression at the same rate as higher doses of the substance. 

Nitrous oxide is an N-methyl-D-aspartate receptor (NMDAR) antagonist and works by blocking the NMDAR. The gas works in a similar way to stronger anaesthetic ketamine, which is also known to treat depression via the FDA-approved intranasal spray treatment, Spravato

Previously, the researchers involved in the present study had tested the effects of a one-hour inhalation session of 50% nitrous oxide on 20 patients with depression. In doing so, they found that patients saw rapid improvements in their symptoms lasting at least 24 hours in comparison to a placebo. However, several patients also experienced negative side effects such as nausea, vomiting and headaches. 

 

Inspired by research on ketamine and depression, the researchers thought to see whether lower doses of nitrous oxide could maximise clinical benefits and minimize negative side effects. They thus set out to find the ‘Goldilocks spot’ for nitrous oxide as a treatment for depression. 

To do so, they repeated a similar protocol with 20 patients, only this time, giving each patient an additional inhalation session with 25% nitrous oxide. In the end, they found that the smaller dose was just as effective as the 50% treatment, and resulted in just a quarter of the negative side effects.

“The reduction in side effects was unexpected and quite drastic, but even more excitingly, the effects after a single administration lasted for a whole two weeks,” says Peter Nagele, one of the researchers behind the study. “This has never been shown before. It’s a very cool finding.”

“There is a huge unmet need. There are millions of depressed patients who don’t have good treatment options, especially those who are dealing with suicidality. If we develop effective, rapid treatments that can really help someone navigate their suicidal thinking and come out on the other side — that’s a very gratifying line of research.”

 

Sources: Neuroscience NewsScience Translational Medicine

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
APR 14, 2021
Cancer
Cell Viability- Where to Begin?
APR 14, 2021
Cell Viability- Where to Begin?
Written By: Author As I pondered the title of this article, my thoughts immediately went back to a request by my Ph.D. a ...
MAY 15, 2021
Drug Discovery & Development
New Drug Blocks Critical Step in Malaria Life Cycle
MAY 15, 2021
New Drug Blocks Critical Step in Malaria Life Cycle
According to the World Health Organization (WHO), in 2019, there were approximately 229 million cases of malaria around ...
JUL 05, 2021
Drug Discovery & Development
ADHD Drug Reduces Daydreaming, Fatigue and Boredom
JUL 05, 2021
ADHD Drug Reduces Daydreaming, Fatigue and Boredom
Researchers led by New York University have found that a stimulant drug may be able to treat persistent daydreaming, fat ...
JUL 18, 2021
Drug Discovery & Development
COVID-19 Antibiotic No More Effective than Placebo
JUL 18, 2021
COVID-19 Antibiotic No More Effective than Placebo
Azithromycin, a broad-spectrum antibiotic commonly used to prevent symptoms of COVID-19 in non-hospitalized patients, do ...
JUL 19, 2021
Microbiology
Engineering a Virus Trap
JUL 19, 2021
Engineering a Virus Trap
Viral infections are difficult to treat - antibiotics only work against bacteria - and there are few effective antibodie ...
JUL 23, 2021
Cancer
New Drug Eradicates Breast Cancer Tumors in Days
JUL 23, 2021
New Drug Eradicates Breast Cancer Tumors in Days
A new drug can kill between 95 and 100% of cancer cells in mice with human estrogen-receptor-positive breast cancer. The ...
Loading Comments...